SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 491 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,235 | +159.9% | 118,455 | +427.5% | 0.03% | +38.1% |
| Q2 2023 | $4,322 | -4.8% | 22,458 | +0.1% | 0.02% | -8.7% |
| Q1 2023 | $4,541 | +57.3% | 22,429 | -0.1% | 0.02% | +43.8% |
| Q4 2022 | $2,887 | -99.9% | 22,462 | -0.2% | 0.02% | -11.1% |
| Q3 2022 | $3,080,000 | -22.7% | 22,507 | -0.0% | 0.02% | -18.2% |
| Q2 2022 | $3,984,000 | +22.4% | 22,516 | -0.3% | 0.02% | +46.7% |
| Q1 2022 | $3,255,000 | -7.5% | 22,594 | -0.7% | 0.02% | +7.1% |
| Q4 2021 | $3,519,000 | -9.3% | 22,759 | -0.4% | 0.01% | -17.6% |
| Q3 2021 | $3,880,000 | +7.4% | 22,853 | -0.1% | 0.02% | +6.2% |
| Q2 2021 | $3,613,000 | +15.4% | 22,886 | +1.5% | 0.02% | +6.7% |
| Q1 2021 | $3,130,000 | -20.5% | 22,539 | +0.2% | 0.02% | -21.1% |
| Q4 2020 | $3,939,000 | – | 22,489 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |